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Summary The incidence of a second primary breast cancer in the contralateral breast among 56,237 women
with a first primary breast cancer diagnosed between the years 1943-80 in Denmark was established. The
relative risk (RR) for a breast cancer patient to get yet another breast cancer was studied, taking account of
age, stage and treatment of the first primary breast cancer. Based on 345,573 women years at risk and 1,840
non simultaneous contralateral breast cancer cases the overall relative risk (RR) of invasive cancer in the
contralateral breast following a first primary breast cancer, was found to be 2.8 (95% Confidence Interval
(CI); 2.7-3.0). Among women who survived 10 or more years the risk was higher among those irradiated for
the primary breast cancer (RR=2.6) than among non-irradiated (RR=2.0). In the large group of patients
with localized disease the association with radiation was obvious for all ages combined (irradiated RR=3.0,
not irradiated RR=1.6), but not obvious among premenopausal (age <45 years) and perimenopausal (age
45-54 years) women at primary breast cancer until followed for 20 years. The RR was higher among
irradiated than non-irradiated post-menopausal (age >55 years) women from the time of diagnosis of the
first cancer, but was not significant after 14 years of follow-up. The probability for a woman diagnosed with
breast cancer at 45 years of age or younger, of developing a contralateral breast cancer if surviving to the age
of 75 years, is 25%. Close surveillance of the remaining breast of breast cancer patients is advised, expecially
if young or following an irradiated localized primary breast cancer.
Cancer of the breast is the most frequent cancer
among women in Denmark (Danish Cancer
Registry, 1983) as well as in most other countries
(Waterhouse et al., 1982). Survival following a
breast cancer is also relatively favourable in
Denmark (Ewertz & Jensen, 1981), and a large
number of patients develop new primary cancers
(Ewertz & Mouridsen, 1985; Harvey & Brinton,
1985), in particular of the contralateral breast
(Harvey & Brinton, 1985).
The risk of a contralateral breast cancer has been
mostly assessed in hospital based series (Haagensen,
1971; Robbins & Berg, 1964; McCredie et al., 1975;
Hislop et al., 1984; Chaudery et al., 1984). A few
population based studies have been reported (Prior
& Waterhouse, 1978; Hankey et al., 1983; Harvey
& Brinton, 1985). The risk of second primary
breast cancer development is inversely related to
age at first breast cancer (Prior & Waterhouse,
1978; Hislop et al., 1984; Harvey & Brinton, 1985;
Chaudery et al., 1984; Robbins & Berg, 1964) and
directly related to the stage of the first cancer
(Hankey et al., 1983).
Radiotherapy has frequently been included in
breast cancer treatment and it has been speculated
that such treatment plays a role for the develop-
ment of a subsequent contralateral breast cancer
(Levitt, 1980). Attention to this possibility has
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increased with the suggestions of minimal surgery
for breast cancer (lumpectomy and axillary dis-
section) (Veronesi et al., 1981; Fischer et al., 1985)
followed by radiotherapy. The doses to the contra-
lateral breast would be in the range of 1-3Gy
(Basco et al., 1985; Benedick et al., 1985), a dose
observed to increase breast cancer risk in human
populations (Mole, 1978). However, the risk of
developing a second breast cancer related to the
radiation treatment of the first primary breast was
only suggested by Hankey et al. (1983), and a
relation could not be confirmed by others (Basco et
al., 1985; McCredie et al., 1975; Harvey & Brinton,
1985). Only the two studies based on data from the
Connecticut Tumor Registry (Hankey et al., 1983;
Harvey & Brinton, 1985) contained sufficient
numbers to detect a small radiation effect. In one
study, an effect of radio-therapy was only observed
among cases treated in recent years (Hankey et al.,
1983). In the other, the overall risk of contralateral
breast cancer was higher among irradiated than in
not irradiated (Harvey & Brinton, 1985) but the
RR decreased with time since diagnosis of the first
breast cancer, which is not in agreement with a
radiation effect. Both studies, however, were based
on data routinely collected by the Connecticut
Tumor Registry, and the validity of the informa-
tion, on treatment was not evaluated.
The present population based study summarizes
more than 38 years experience of contralateral
breast cancer among 56,237 women with breast
cancer in Denmark. The risk is investigated in
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relation to age, stage and treatment of disease at
the primary breast cancer diagnosis, which has been
recorded in a uniform manner since 1943. The
possible effect of radiation treatment on the sub-
sequent breast cancer risk is evaluated in this large
cohort of women followed for a sufficiently long
time to take account of latency between exposure
and possible cancer development.
Materials and methods
The Danish Cancer Registry is a population based,
national cancer registry founded in 1942 and
incidence data are available since 1943. Reports are
received on newly diagnosed cancers by agreement
between the National Board of Health, the Danish
Medical Association and the Cancer Registry.
Multiple reports are received for each case. A fee
has been paid for each notification, and although
reporting is voluntary several validation studies
have shown that the registration may be regarded
as complete (Clemmesen, 1965; 0sterlind & Jensen,
1985), and similar to compulsory cancer registration
schemes where completeness has been assessed
(Lund, 1981). The registry is tumour based and
uses an extended version of the seventh revision of
the International Classification of Diseases (World
Health Organization, 1957) for classification of
cancers as described in detail by Jensen et al.
(1985).
Cancers of paired organs are recorded as one
tumour, with the date of the first cancer taken as
date of diagnosis. However, primary bilateral breast
cancers (i.e. simultaneous development within one
month of left and right sided breast cancer) and
contralateral breast cancer, defined as non-
simultaneous independent cancer development in
both breasts, are indicated by a special code in the
tumour record. The decision of the presence of two
independent breast cancers is left to the notifying
physician and pathologist (Jensen et al., 1985), who
in general comply with the rules of Robbins & Berg
(1964) (Nielsen et al., 1986). Whenever the registry
is in doubt as to the tumour diagnosis reported, the
notifying physician is contacted.
Validation of cancer registry information
Information on stage and treatment is recorded
routinely. For all incident cases reported until 1977
no distinction was made in the coding, no radio-
therapy and no information reported.
As part of this study the coding of information
on treatment was therefore evaluated. Among the
2,588 patients with more than one breast cancer,
88.9% (1,451) of the ones classified as irradiated
were reported as such, while 8.5% should have
been classified as treatment unknown and 2.6% as
not irradiated. Among those 1,137 patients
classified as not irradiated (incl. treatment
unknown), 35.0% should be classified as treatment
unknown, 37.0% as irradiated and 28.0% as truly
not irradiated.
A further validity check was performed by
linking the registry information to the detailed
information of treatment obtained in the Danish
part of a study on second primary breast cancer
following cancer of the cervix uteri (Day & Boice,
1983). Out of 243 second primary breast cancer
cases, 26 (10.7%) had never been reported to the
registry. Among the remaining 217 cases, 88.9%
(112) of those coded as irradiated were in fact
irradiated.for breast cancer, whereas 45% (41) of
those classified as not irradiated (i.e. not irradiated
or radiation unknown) were in fact irradiated. In
conclusion then some 90% of breast cancers
classified as 'irradiated' are truly so, whereas some
40% of those 'non-irradiated' or 'irradiation
unknown' were infact irradiated and this obviously
limits the value of this latter group for comparison.
Cohort ofbreast cancer patients
A total of 56,809 notified breast cancer cases
diagnosed between January 1, 1943 and December
31, 1980 survived for more than 1 month.
Altogether 2,588 or some 4.5% of the records were
marked as either bilateral or contralateral breast
cancer cases. The records of these cases were
identified in the registry card file, and they were
recoded with respect to date of diagnosis of second
primary breast cancer and laterality, while ICD-O
topography and morphology (WHO, 1976) were
recoded for both the first and second primary
breast cancers. The treatment was taken as coded
routinely by the registry. The unilateral breast
cancers were found to be correctly coded as such
by recoding a random sample of 493 breast cancer
cases from the years 1943 to 1980.
There was histological confirmation for 95% of
the first primary breast cancers (Ewertz &
Mouridsen, 1985) and 84% of the second breast
cancers. Some 44% of the first and second breast
cancers had different morphologies to the 4-digit
level of the ICD-O.
Altogether 572 bilateral breast cancer patients
were excluded from the study cohort. On recoding,
176 women were not counted as having developed a
new cancer, as they were incorrectly coded (122
cases) or the contralateral 'cancer' was a benign or
a carcinoma in situ lesion (54 cases). Altogether
56,237 women thus remained in the cohort for
analysis. Excluding coding errors and simultaneous
breast cancer cases, 1840 contralateral breast
cancers were observed and included in the study.CONTRALATERAL BREAST CANCER IN DENMARK 485
Based on the age-specific incidence of contra-
lateral breast cancer during the period 1943-80 the
probability of developing contralateral breast
cancer before the age 75 years was estimated as the
cumulative incidence (Day, 1982). For comparison,
the expected probability for breast cancer in the
general population was calculated.
Follow-up and analysis
Follow-up information necessary for analysis has
been recorded routinely by the Danish Cancer
Registry, as the total register has been matched
annually with all deaths since 1943, and dates of
deaths recorded. Women for whom no date of
death was present were considered to be alive.
Emigration may be regarded as negligible among
these patients as only 0.5% of the entire Danish
population emigrated in the years 1941-80
(Danmarks Statistik, 1985). Person-years at risk
were calculated from the time of diagnosis of the
first breast cancer until the diagnosis of a cancer in
the contralateral breast, date of death, December
31, 1980 or age 100 years (Monson, 1974),
whichever occurred first. Expected numbers were
computed by multiplying the person-years at risk in
5 year age and calendar periods with the corres-
ponding incidence rates for breast cancer in all of
Denmark, thereby adjusting indirectly for age and
calendar time effects when summed over the cells
(Monson, 1974). Relative risks (RR) were obtained
by dividing the observed by the expected number of
cases, and 95% confidence limits of the RR were
calculated, assuming a Poisson distribution
(Rothman & Boice, 1982). Tests for trend were
conducted as described by Armitage (1955) using
programs for a programmable calculator (Rothman
& Boice, 1982). Tests for difference between
observed and expected ratios were carried out as
described by Haldane (1955).
The 56,237 primary breast cancer patients under
study accrued 345,573.5 person-years of observation
with an average age at diagnosis of 60.2 years and
an average follow-up period of 6.2 years (Table I).
Some 69% of the patients were recorded as
receiving radiotherapy as part of the initial treat-
ment. The highest proportion irradiated was among
patients with regional metastasis at primary
diagnosis (77%-88%) and lowest if the stage was
unknown. Generally across all stages fewer patients
aged 55 years or more at diagnosis were irradiated.
For irradiated and non-irradiated women the mean
ages within the various age-groups are similar
except that patients not receiving radiation tend to
be older than the irradiated women, if aged 55 or
more years at primary breast cancer diagnosis. The
patients that received radiation as primary treat-
ment were on average followed 1.1 years longer
than the ones that did not receive radiation, but
this can be attributed to the longer,follow-up of the
women in the age-group 55+ years at diagnosis.
Eleven of the contralateral breast cancer cases
were reported treated at first primary breast cancer
with tamoxifen or cytotoxic drugs alone or in
combination. These cases were diagnosed in the
calendar period 1978-80 and are included in the
analysis.
Results
Table II shows that the overall RR of second
primary breast cancer development is 2.8. The RR
decreases from 5.5 if a woman is <45 years old at
first breast cancer diagnosis to 2.1 if she is 55 years
or more. A 60% significant difference (CI 95%, 40-
80%) is observed between the RR's of age group
<45 years and 45-54 years and between age group
45-54 years and 55+ years irrespective of treat-
ment, as well as a significantly decreasing trend in
RR is observed by increasing age (Ptrend <0.001).
The non-irradiated patients overall have a
significantly higher RR for contralateral breast
cancer than the irradiated patients.
The RR by treatment and years since first breast
cancer is given in Table III. The overall relative risk
is significantly increased in all time periods. A slight
decrease in RR from 3.1 within the first 5 years of
observation to 1.9, 25-29 years after primary
diagnosis is observed, but the RR then increases
among patients observed 30 or more years. The RR
among irradiated patients is virtually stable during
the first 20 years of observation (RR=2.1-2.8) with
an indication of an increase (RR=4.2) 30 years or
more after initial treatment. Among non irradiated
patients on the contrary the RR are higher during
the first 14 years of observation (RR=4.6-2.6), but
declines to 1.6 15-19 years after and to insignificant
levels of RR=1.5 20-29 years after initial treat-
ment. As for the irradiated patients an increase in
RR is observed after 30 years of observation.
If the first 9 years of observation are excluded,
where a radiation effect would be less likely and the
data less influenced by misclassification of
metastasis, a significant 30% (CI 95%: 10-40%)
difference between the irradiated (RR=2.6) and the
non-irradiated groups (RR=2.0) emerges.
The RR of second primary breast cancer by age,
stage and treatment of the first primary breast
cancer excluding-the first 4 years of observation is
presented in Table IV. No change in the inverse
relationship of contralateral breast cancer risk by
age is observed, when stratifying for stage and
treatment with irradiation. Among irradiated
women the RR of second primary breast cancer
increases with stage irrespective of age, with the486 H.H. STORM & O.M. JENSEN
Table I Number of patients, average age at diagnosis of the primary breast cancer, average years of follow-up
and number of person-years for the various cohorts of patients included in the analysis of contralateral breast
cancer risk in Denmark 1943-80
Average
Average age follow-up Number of
Number ofpatients (years) (years) person-years
Radiation Radiation Radiation Radiation
Yes % Noa % Yes NOa Yes Noa Yes Noa
Extent of disease
age group
Localized
<45 years 3,039 79.3 793 20.7 39.7 39.5 7.8 6.8 23,808.9 5,352.1
45-54 vears 5,354 80.9 1,267 19.1 50.0 49.9 8.0 7.0 43,044.4 8,666.9
>55 years 2,306 70.0 5,263 30.0 67.1 72.8 6.5 4.5 79,806.7 23,037.9
Regional
<45 years 971 87.5 139 12.5 39.1 39.6 4.5 5.3 4,323.6 735.8
45-54 years 1,620 87.8 226 12.2 50.1 50.5 4.9 4.9 7,978.9 1,042.0
>55 years 4,389 76.7 1,335 23.3 67.7 74.1 3.6 2.7 15,900.4 3,612.9
Distant
<45 years 172 69.6 75 30.4 40.0 39.7 4.1 3.4 700.7 263.4
45-54 years 360 67.9 170 32.1 50.3 50.9 3.3 2.4 1,168.6 426.9
>55 years 1,037 46.4 1,198 53.6 67.5 72.0 2.3 1.4 2,331.9 1,580.4
Unknown
<45 years 1,762 63.3 1,021 36.7 39.5 39.5 11.2 12.3 19,743.0 12,526.0
45-54 years 2,422 60.5 1,582 39.5 49.9 49.8 9.7 10.5 23,545.5 16,312.8
>55 years 5,147 52.9 4,589 47.1 67.1 69.3 5.4 4.8 27,527.0 22,394.3
All Stages
<45 years 5,944 74.6 2,028 25.4 39.6 39.5 8.2 9.3 48,568.5 18,878.6
45-54 years 9,756 75.0 3,245 25.0 50.0 50.0 7.8 8.2 75.719.3 26,454.8
>55 years 22,879 64.9 12,385 35.1 67.2 71.6 5.5 4.1 125,509.8 50,647.1
All 38,579 68.6 17,658 31.4 58.5 63.9 6.5 5.4 249,630.9 95,942.6
aNo radiation includes radiation unknown.
Table II Relative risk of cancer of the contralateral breast among women with breast cancer in Denmark 1943-80 in
relation to age at first breast cancer and initial treatment
Age of Irradiated Non-irradiateda All
diagnosis
(years) 0 E RR 95% CI 0 E RR 95% CI 0 E RR 95% CI
<45 269 57.5 4.7 (4.1-5.3) 167 22.5 7.4 (6.3-8.6) 436 80.0 5.5 (5.0-6.0)
45-54 359 120.3 3.0 (2.7-3.3) 188 41.4 4.5 (3.9-5.2) 547 161.7 3.4 (3.1-3.7)
>55 544 285.1 1.9 (1.8-2.1) 313 121.7 2.6 (2.3-2.9) 857 406.8 2.1 (2.0-2.3)
Total 1,172 462.9 2.5 (2.4-2.7) 668 185.6 3.6 (3.3-3.9) 1,840 648.5 2.8 (2.7-3.0)
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Table III Observed numbers and RR of contralateral breast cancer by treatment
and time since first breast cancer in Denmark 1943-80
Years since Irradiation No irradiationa All
first breast
cancer 0 RR CI 95% 0 RR CI 95% 0 RR CI 95%
0-4 563 2.5 2.3-2.7 414 4.6 4.1-5.0 977 3.1 2.9-3.3
5-9 282 2.5 2.2-2.8 136 3.8 3.1-4.4 418 2.8 2.5-3.1
10-14 153 2.5 2.1-2.9 59 2.6 2.0-3.3 212 2.5 2.2-2.9
15-19 87 2.6 2.1-3.2 26 1.6 1.1-2.4 113 2.3 1.9-2.7
20-24 52 2.8 2.1-3.7 17 1.5 0.9-2.4 69 2.3 1.8-2.9
25-29 19 2.1 1.3-3.3 9 1.5 0.7-2.9 28 1.9 1.2-2.7
30+ 16 4.2 2.3-6.7 7 3.3 1.3-6.9 23 3.8 2.4-5.8
Total
excluding
0-9 years 327 2.6 2.3-2.9 118 2.0 1.7-2.4 445 2.4 2.2-2.6
aNo irradiation includes radiation unknown.
Table IV Relative risk of contralateral breast cancer among women with breast cancer in
Denmark 1943-80 by age at diagnosis, extent of disease and radiation treatment to the first
breast cancer (observed and expected number of cases during first 5 years of follow-up
excluded)
Irradiated Not irradiateda
<45b 45-54 55+ <45 45-54 55+
Stage years years years years years years
O 84 129 192 16 17 22
E 16.6 36.8 82.2 4.2 8.0 22.6 Local RR 5.1 3.5 2.3 3.8 2.1 1.0
95% CI 4.0-6.3 2.9-4.2 2.0-2.7 2.2-6.2 1.2-3.4 0.6-1.5
O 15 24 26 0 3 2
Regional E 2.5 5.7 11.4 0.5 0.7 2.2
metastases RR 6.0 4.2 2.3 0.0 4.3 0.9
95% CI 3.4-9.9 2.7-6.3 1.5-3.3 0.0-7.3 0.9-12.5 0.1-3.3
O 6 3 7 0 2 2
Distant E 0.3 0.6 1.2 0.2 0.2 0.7
metastases RR 20.0 5.0 5.8 0.0 10.0 2.9
95% CI 7.3-43.5 1.0-14.6 2.3-12.0 0.0-18.3 1.1-36.1 0.3-10.3
O 29 52 42 47 52 91
E 20.1 28.1 32.9 12.7 19.2 40.9 Unknown RR 1.4 1.9 1.3 3.7 2.7 2.2
95% CI 1.0-2.1 1.4-2.4 0.9-1.7 2.7-4.9 2.0-3.6 1.8-2.7
O 134 208 267 63 74 116
All E 39.5 71.3 127.7 17.5 28.2 49.3
RR 3.4 2.9 2.1 3.6 2.6 2.4
95% CI 2.8-4.0 2.5-3.3 1.8-2.4 2.8-4.6 2.1-3.3 1.9-2.8
aNot irradiated includes radiation unknown; bage at diagnosis of first breast cancer.488 H.H. STORM & O.M. JENSEN
lowest values following a localized primary breast
cancer and the highest values if the first primary
breast cancer had distant metastasis. Numbers are
too small to evaluate the influence of stage in the
non-irradiated group.
For the large group of women with localized
disease there is a significant higher risk among
irradiated women followed for 5 or more years
irrespective of age (405 observed, 135.6 expected,
RR=3.0; CI 95%; 2.7-3.3) than among non-
irradiated (55 observed, 34.8 expected RR=1.6;
CI 95%; 1.2-2.1) (Table IV). However taking age
at primary breast cancer into consideration, the
observed number of cases is small and confidence
intervals thus wide in particular for the non-
irradiated group (Figure 1). No major difference in
RR is seen between irradiated and non-irradiated
premenopausal (<45 years) and menopausal (45-54
years) women during the first 19 years of follow-up.
By contrast a slightly increasing risk, significantly
different between irradiated and not irradiated
postmenopausal women (55+ years), is observed
10-14 years after first breast cancer. The difference
remains throughout the follow-up period, however
numbers in the non-irradiated group are too small
to make the difference significant.
Discussion
The RR or incidence of contralateral breast cancer
has previously been assessed, mostly in hospital
based studies (Haagensen, 1971; Robbins & Berg,
1964; Schottenfeld & Berg, 1971; McCredie et al.,
1975; Hislop et al., 1984; Chaudery et al., 1984).
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Figure 2 Cumulative risk of developing breast cancer
before the age of 75 years for women with and
without breast cancer at different ages. Probability of
breast cancer (---) and of contralateral breast cancer
( )-
The risk estimates of these often smaller studies are
in concordance with those obtained in population
based studies (Prior & Waterhouse, 1978; Hankey
et al., 1983; Harvey & Brinton, 1985) with an
incidence of 3.8-7.1 per 1000 women-years. With
345,000 women-years of observation the present
study is the largest population based investigation
of contralateral breast cancer risk till now. The RR
including more than 30 years of observation is 2.8,
which corresponds to a crude incidence of 5.3 per
1000 women-years.
The RR of 2.8 found in our study is similar to
the ones seen in Connecticut RR=3.0-3.2 (Hankey
et al., 1983; Harvey & Brinton, 1985) and
Birmingham RR=2.4 (Prior & Waterhouse, 1978).
45-54 years 55+ years
0.1- '
0-4 5-9 10-1415-19 20+ 0-4 5-910-1415-19 20+ 0-4 5-9 10-1415-19 20+
Years since primary breast cancer
Figure 1 Relative risk of contralateral breast cancer, by age, treatment and time since a localized primary
breast cancer. Irradiated (---); non-irradiated ( ).
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The similarities of the risk estimates from different
studies are noteworthy considering the various
definitions used for second primary breast cancer.
Many authors (Prior & Waterhouse, 1978;
Chaudery et al., 1984; Basco et al., 1985; Nielsen et
al., 1986) attempt to exclude metastatic spread of
the first breast cancer accepting the second by
applying the rules of Robbins & Berg (1964) which
either require a difference in morphology between
the two tumours or presence of contiguous in situ
lesions associated with the second primary invasive
breast cancer. Whether these rules have been
applied by the reporting physicians in Denmark is
unknown. Prior & Waterhouse (1978) obtained
conservative estimates by excluding all primaries
with known metastases, as the present study and
the Connecticut studies (Harvey & Brinton, 1985;
Hankey et al., 1983) may have done, by excluding
all simultaneous cases (developing within the first
months of observation, one and two respectively).
To minimize the influence of misclassified
metastasis we excluded the numbers from the first 5
years of observation from some of the totals,
thereby excluding 50% of all contralateral breast
cancers and lowering the overall risk from 2.8 to
2.4. However, a recent Danish study on the
pathology of second primary breast cancer (Nielsen
et al., 1986) indicates that approximately 50% of all
second primary breast cancer does occur within this
time interval
The RR for contralateral breast cancer seen in
this investigation (Table II) is significantly increased
for both premenopausal (age<45 years),
menopausal (age 45-54 years) and postmenopausal
(age 55+ years) women, but decreases with
increasing age at first breast cancer. This is in
agreement with previous observations (Hankey et
al., 1983; Prior & Waterhouse, 1978). A significant
decreasing RR with increasing age (P<0.05) is
present (Tables II and IV), and seen during the
years of follow-up irrespective of treatment
(Figure 1). The trend 15 and more years after
diagnosis is difficult to evaluate, as the findings are
influenced by small numbers. Considering only pre-
and post-menopausal women (age <45 years, age
55+ years) all stages and treatments combined, a
difference in RR between these two age groups is
present in all time intervals since primary breast
cancer, but this is not significant after 15 years of
follow-up.
It has been suggested that young breast cancer
patients represent a genetically predisposed group
(Anderson, 1977) and this has been offered as an
explanation for the particular increased RR of
contralateral breast cancer among young women
(Anderson, 1977; Prior & Waterhouse, 1978;
Fraumeni, 1977). However, a case control study
among patients with contralateral breast cancer in
Sweden showed no increased RR with a positive
family history (Adami et al., 1981). Another
explanation for the high risk observed may be that
young breast cancer patients represent a group
more exposed to exogenous risk factors than older
patients.
The stage of the first primary breast cancer
(Table IV) is directly related to the risk of second
primary breast cancer as women with a localized
first breast cancer have the lowest RR. Stage is,
however, a weak risk factor and it is associated
with a significant risk elevation between the
localized and the distant metastatic primary breast
cancers only among the young irradiated women. A
similar influence of stage at first primary breast
cancer was observed by Hankey et al. (1983), and
attributed to possible genetic predisposition if node-
involvement (metastatic spread) was present at
initial diagnosis.
Radiation is a known risk factor for breast
cancer (MacMahon et al., 1973; Cole, 1980), and
there is evidence of a latent period of at least 5-15
years between exposure and breast cancer
development (Baral et al., 1977; Boice & Monson,
1977; Land, 1980a, Land et al., 1980b). The risk
associated with radiation continues throughout
life, based on data with exposure to radiation
before (Tokunaga et al., 1982) and after puberty
and before menopause. Uncertainties exist about
breast cancer risk from exposures after menopause
(Land, 1980). In the present study irradiated
women followed for 10 or more years have a RR of
2.6, which is significantly higher than among the
non-irradiated (RR 2.0) (Table III). This approxi-
mately 30% higher risk among the irradiated
women may be regarded as conservative, as some
40% of the 'non-irradiated' women in fact received
radiotherapy, which may have elevated the level of
risk in the comparison group. Misclassification of
radiation exposure may also be larger for contra-
lateral breast cancer patients than for single breast
cancer cases, as only 56% of the first primary
breast cancers among contralateral cases were
classified as irradiated, contrary to 69% of the
single breast cancer patients. The RR observed may
thus be even more conservative than what would be
attributable to a proportional shift in exposure
category. This is. further supported by our experi-
ence from a study of second cancer following
cancer of the cervix uteri where the recorded
elevation of RR among the irradiated women
would be conservative due to misclassification of
treatment, especially among patients with more
than one cancer (Storm & Boice, 1985a; Storm et
al., 1985b). The RR is thus likely to be under-
estimated in the irradiated group and overestimated
in the non-irradiated group.
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difficult to evaluate in women with metastasis at
first breast cancer diagnosis. When considering only
the largest group of patients with a localized
primary breast cancer, we find consistent higher
RR's in all age-groups irradiated than among non-
irradiated women surviving 20 years or more
(Figure 1). However, the difference is only
significant for ages 45-54 years at initial diagnosis
or when all ages are combined but the difference in
RR between the two treatment groups is likely to
be underestimated as mentioned earlier. The present
findings are thus in concordance with a possible
influence of radiation on breast cancer risk of long
term surviving women with breast cancer in
particular at premenopausal and menopausal age.
The increase in RR for women irradiated below age
45 years, between 45 and 54 years and after 55
years of age is expressed at ages above 60 years,
indicating an interplay of both an age effect and a
radiation effect, among long term survivors.
The contralateral breast may receive between 50-
200cGy by the treatment of the primary breast
cancer (Benedick et al., 1985). With current risk
estimates for radiogenic breast cancer (6.6
cases/rad/106 women-years) (Land et al., 1980) this
would give rise to 82-329 breast cancers or account
for 11-46% of the observed excess among the
irradiated in our study. Risk estimates for
radiation-induced breast cancer is based on
sufficient data for women aged below 40 at
exposure (Land et al., 1980), whereas data on
women aged 50 or more years at exposure are less
reliable due to small numbers (Tokunaga et al.,
1979). Baral et al. (1977) reported a decreasing
excess risk per rad with increasing age at exposure
(although dose was highly correlated with age at
treatment), a finding supported by animal data
quoted in the report from the committee on the
biological effects of ionizing radiations (BEIR)
(1980). The average age at exposure in our study
was 60 years and the number of cancers attributed
to radiation may be smaller than estimated.
A recent study by Basco et al. (1985) found no
evidence of radiation-induced carcinogenesis among
194 contralateral breast cancer patients with an
average exposure of 138-321 cGy to the contra-
lateral breast. However, the study population was
small and included only 44 contralateral breast
cancer cases observed for a sufficient time period
(>10 years) after exposure to be able to observe
any effect of radiation. In addition some 50% of
these 44 patients are suspected to be above the age
of 50 years at exposure, where a radiation effect is
likely to be less pronounced (Land et al., 1980).
In summary then the present study confirms that
women with breast cancer are at increased risk of
developing a new clinically manifest primary cancer
of the contralateral breast. The risk is influenced by
the age at diagnosis, the stage of the disease when
first diagnosed, and possibly by radiotherapy to the
first breast cancer. In addition to the possible leads
from these observations it is important from a
clinical aspect that some 25% of women with breast
cancer below the age of 45 years develop a contra-
lateral breast cancer if surviving to the age of 75
years, while 6% of women aged 55 years or more
at diagnosis are likely to get a new breast cancer
(Figure 2). These probabilities are in agreement
with the observations reported by Foote & Steward
(1945) and Robbins & Berg (1964). As the
increased RR persists it is important to follow
especially young breast cancer patients clinically
with respect to new breast cancer development for
life.
Clarification of the role of radiation in breast
cancer development is important, especially con-
sidering treatment of primary localized breast
cancer with partial mastectomy/lumpectomy,
axillary dissection and adjuvant radiotherapy. The
,present study is supportive of breast cancer induc-
tion as a long term side-effect of radiation. The role
of radiation in the development of cancer of the
contralateral breast can only be completely assessed
in a well designed study among long .erm survivors
with individual radiation dosimet gerformed. Co-
ordinated case control studies in Denmark and
Connecticut that address this issue are under way.
Studies of other exogenous factors related to both
the primary and the contralateral breast cancer are
also needed, for the identification of high risk
groups.
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